The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life
Jane L. Wang, , David Limburg, Matthew J. Graneto, John Springer, Joseph Rogier Bruce Hamper, Subo Liao, Jennifer L. Pawlitz, Ravi G. Kurumbail, Timothy Maziasz, John J. Talley, James R. Kiefer, , Jeffery Carter
Bioorganic & Medicinal Chemistry Letters, Volume 20, Issue 23, 1 December 2010, Pages 7159–7163
- DOI:
http://dx.doi.org/10.1016/j.bmcl.2010.07.054